Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
Current HIV/AIDS Reports (2023) Vol. 20, Iss. 2, pp. 51-75
Open Access | Times Cited: 25

Showing 25 citing articles:

NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins
Ilya Tsukalov, Ildefonso Sánchez‐Cerrillo, Olga Rajas, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Macrovascular Function in People with HIV After Recent SARS-CoV-2 Infection
Ana S. Salazar, Louis Vincent, Bertrand Ebner, et al.
Journal of Vascular Diseases (2025) Vol. 4, Iss. 1, pp. 4-4
Open Access
Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
Jianhui Yang, Esben Strodl, Dandan Zhang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Six-month immune responses to mRNA-1273 Vaccine in cART-treated late presenter people living with HIV according to previous SARS-CoV-2 Infection
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
AIDS (2023) Vol. 37, Iss. 10, pp. 1503-1517
Open Access | Times Cited: 11
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio
Alessandra Vergori, Alessandro Tavelli, Giulia Matusali, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1664-1664
Open Access | Times Cited: 11
Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV
Alessandra Vergori, Giulia Matusali, Alessandro Cozzi Lepri, et al.
International Journal of Infectious Diseases (2023) Vol. 134, pp. 195-199
Open Access | Times Cited: 10
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach
Giorgio Montesi, Matteo Augello, Jacopo Polvere, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108673-108673
Open Access | Times Cited: 7
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study
Cecilia T. Costiniuk, Terry Lee, Joel Singer, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 447-447
Open Access | Times Cited: 1
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in People Living with HIV (PLWH)
Maxim Cherneha, Isabel Zydek, Peer Braß, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 785-785
Open Access | Times Cited: 1
A Systematic Review of Factors Associated with COVID-19 Vaccine Uptake, Hesitancy, and Acceptability Among Adults with HIV: Implications for Integrating COVID-19 Immunization into HIV Care
Aaliyah Gray, Seyedeh Yasaman Alemohammad, Daisy Ramírez‐Ortiz, et al.
AIDS Patient Care and STDs (2024)
Closed Access | Times Cited: 1
The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications
Debashis Dutta, Jianuo Liu, Huangui Xiong
Viruses (2023) Vol. 15, Iss. 5, pp. 1117-1117
Open Access | Times Cited: 4
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a Machine Learning approach
Giorgio Montesi, Matteo Augello, Jacopo Polvere, et al.
Research Square (Research Square) (2024)
Open Access
Impact of SARS-CoV-2/COVID-19 on HIV-1-associated neurocognitive disorders
Debashis Dutta, Jianuo Liu, Huangui Xiong
Elsevier eBooks (2024), pp. 355-378
Closed Access
Difference of Omicron variant infection and influence factors between people with and without HIV infection
Jianhui Yang, Esben Strodl, Dandan Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Prolonged course of novel coronavirus infection COVID-19 with the formation of pulmonary fibrosis in an HIV-infected patient
M. A. Savchenko, В. Б. Мусатов, Д. А. Гусев, et al.
Journal Infectology (2024) Vol. 16, Iss. 1, pp. 87-93
Open Access
Vaccination against COVID-19 among healthcare workers as a cocoon strategy for people living with HIV
Agata Skrzat‐Klapaczyńska, Justyna D. Kowalska, Filip Fijołek, et al.
Journal of Virus Eradication (2024) Vol. 10, Iss. 2, pp. 100377-100377
Open Access
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients’ survival and long COVID
Maddalena Noviello, Rebecca De Lorenzo, Raniero Chimienti, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Severe acute respiratory syndrome coronavirus-2 seroprevalence in non-vaccinated people living with HIV in Uganda during 2022
Provia Ainembabazi, Letisha Najjemba, Joseph Musaazi, et al.
Frontiers in Virology (2024) Vol. 4
Open Access
Immunogenicity and Determinants of Antibody Response to the BNT162b2 mRNA Vaccine: A Longitudinal Study in a Cohort of People Living with HIV
Tatjana Baldovin, Davide Leoni, Ruggero Geppini, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1172-1172
Open Access
Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New Thiazolidinone Derivatives as NNRTIs and SARS‐CoV‐2 Main Protease Inhibitors
Maria Fesatidou, Anthi Petrou, Athina Geronikaki
Chemistry & Biodiversity (2024)
Open Access
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
AIDS (2024) Vol. 38, Iss. 14, pp. 1987-1990
Closed Access
ARE HIV-INFECTED PEOPLE AT RISK GROUP FOR COVID-19 MORBIDITY AND SEVERE COURSE?
В. И. Сергевнин, M. V. Rozhkova
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 6, pp. 1131-1138
Open Access
Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study
Elena Vázquez‐Alejo, María de la Sierra Espinar-Buitrago, Esmeralda Magro-López, et al.
Medical Microbiology and Immunology (2024) Vol. 214, Iss. 1
Open Access
Individuals with HIV are likely targets for long COVID
Iulia Filip
AIDS (2023) Vol. 38, Iss. 2, pp. N3-N4
Open Access
Page 1

Scroll to top